Home
About us
Annual Meeting Abstracts
Annual Meeting
Annual Meeting

Annual Meeting Abstracts

28th Annual Meeting of the Japanese Society of Clinical Neuropsychopharmacology jointly with 48th Annual Meeting of Japanese Society of Newropsychopharmacology

November 14-16, 2018
Tokyo Dome Hotel ,Tokyo ,Japan

FIRST AUTHOR INDEX
First Name Middle Name Last Name No. Title
Joseph R.Joseph SL Recognition, Treatment, Morbidity and Mortality in Bipolar Disorder
TOMIKI SUMIYOSHI JS5-2 Cognitive impairment in mood disorders; its assessment and therapeutics
TADAFUMIKATO S8-1 Phenotypic discordance of iPS cells-derived neurons/cerebral organoids between monozygotic twins discordant for schizoaffective bipolar disorder
HARUHISAINOUE S8-4 Disease modeling and drug discovery using iPSC platform
KAZUHIROHAYASHI S20-2 Game change of scholarly communication enhanced by Open Science and its policy
TOSHIAKIFURUKAWA PJ1 Comparative efficacy and acceptability of 21 antidepressantdrugs for the acute treatment of adults with major depressive disorder: a systematic reviewand network meta-analysis
SAKIHATTORI EN2 Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia
KENTAROONIKI EN3 Association between oxidative stress-related genes polymorphisms and metabolic abnormalities among schizophrenia patients
ShitijKapur LS1-3 Dopamine and Antipsychotics:Past, Present and Future
JosephR.Calabrese LS2-1 Early Intervention in the Diagnosis and Treatment of Bipolar Disorder and Schizophrenia
MarkZimmerman SS2-1 Things That You Think You Know That May Not Be True in the Diagnosis and Treatment of Depression
KAZUNARIYOSHIDA O2-3 A preliminary multi-genic prediction model for antipsychotic-induced weight gain
RYOSUKEARAKAWA O3-1 Norepinephrine transporter occupancy of venlafaxine extended-release in patients with major depressive disorder using positron emission tomography and radioligand [18F]FMeNER-D2
TAKASHIOHNISHI O5-1 Disrupted structural connectivity and less efficient network brain in the schizophrenia revealed by graph theoretical analysis
GENTAROMIURA O6-2 Hospitalization-preventing effect of Long-Acting Injectable Versus Oral AntipsychoticsA Retrospective Bidirectional-Mirror-Image Study in Japanese Psychiatric Hospitals
YUYAMIZUNO O7-4 Heterogeneity of antipsychotic efficacy in treatment resistant schizophrenia: A meta-analysis
FUMIHIKOUENO O9-2 Influence of Alcohol and Acetaldehyde on Human Psychomotor Functions: Findings from the Alcohol Clamping in Healthy Young Population
MAKOTOISHITOBI O10-2 Paroxysmal kinesigenic dyskinesia associated with depression in a bipolar patient with comorbid idiopathic basal ganglia calcification
KAOSUMATSUMORI O11-2 A Computational Psychiatric Model with Exponentially Biased Bayesian Inference for Mental Diseases
KAZUTAKAOHI O12-2 Genome-wide variants shared between smoking quantity and schizophrenia on 15q25 are associated with CHRNA5 expression in the brain
MarcoRiva O12-3 Anti-stress and neuroplastic effects of blonanserin in preclinical models
YOKINAKAMURA O13-2 Sigma-1 receptor plays a key role in the control of extracellular vesicle release by modulating the activity of the ADP-Ribosylation Factor 6 at the mitochondrion-endoplasmic reticulum interface
SHINICHIRONAKAJIMA O14-1 Glutamatergic Neurometabolite Levels in Major Depressive Disorder: A Systematic Review and Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies
TAKUMAINAGAWA P1-4 A meta-analysis of the effects of multi-session transcranial direct current stimulation on cognition in dementia and mild cognitive impairment.
TAKASHIOHNISHI P3-2 The large scale disturbed white matter fibre in schizophrenia revealed by local connectometry
YUZURUKATAOKA P4-4 Difference in executive function among with patients with schizophrenia, their first degree relatives and healthy subjects
YUSUKEIWATA P6-1 Glutamatergic Neurometabolite Levels in Patients with Ultra Treatment-Resistant Schizophrenia: a Cross-sectional 3T Proton MRS study
KENINADA P6-5 Analysis of clozapine use and safety using comprehensive national data from the Japanese Clozapine Patient Monitoring Service
SHINKUROSE P7-1 Time Courses of Central Dopamine D2 Receptor Occupancy and Peripheral Blood Concentrations of Antipsychotics: A Systematic Review
SAKIHATTORI P9-5 Associations of ABCB1 gene polymorphisms with aripiprazole-induced autonomic nervous system dysfunction in schizophrenia
KYOSUKESAWADA P14-1 Impact of subjective vs. objective remission status on subjective cognitive impairments in depression
CynthiaSiu P19-1 NETWORK MODEL OF DEPRESSIVE AND MANIC SYMPTOMS IN THE STEP-BD STUDY
TOSHINORISHIRATAP27-6 Relationship of high neuroticism with increased methylation of the BDNF gene in healthy subjects


Jscnp Japanese